The Lancet-Oncology：New breakthrough in treatment of “most toxic breast cancer”
Recently, "The Lancet-Oncology" published the results of a randomized controlled umbrella phase II clinical study from China called "FUTURE-SUPER" for...
metastatic triple-negative breast cancer
